Results from a recently published randomized, double-blind, placebo-controlled clinical trial show that supplementation with ...

More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for ...

Any striking marketing claims in companies’ ads about the gut benefits of a popular probiotic may be full of, well, the same thing that has their target audience backed up. The study adds to a mixed ...

ScreenPoint Medical, The Breast AI Company, highlights new research from Sweden's Mammography Screening with Artificial Intelligence (MASAI) large-scale randomized controlled trial, which shows that ...

Telesurgery (operating on a patient remotely using a surgical robot via a secure telecommunication link) appears to be as ...

Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial From March 2022 to December 2023, a ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

STARS DAPT is an investigator-initiated, prospective, multicentre, international, open-label, randomized controlled pilot ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis ...